The study on the relationship between renin activity and hypotensive efficacy of uncombined angiotensin II receptor blockers(ARB) therapy and combined ARB+diuretic therapy for hypertension.

Trial Profile

The study on the relationship between renin activity and hypotensive efficacy of uncombined angiotensin II receptor blockers(ARB) therapy and combined ARB+diuretic therapy for hypertension.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Telmisartan (Primary) ; Hydrochlorothiazide
  • Indications Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 17 Dec 2011 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network-Japan.
    • 11 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top